X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs STRIDES SHASUN LTD - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA STRIDES SHASUN LTD ABBOTT INDIA/
STRIDES SHASUN LTD
 
P/E (TTM) x 33.0 14.3 231.2% View Chart
P/BV x 8.2 1.9 426.8% View Chart
Dividend Yield % 0.8 0.5 151.0%  

Financials

 ABBOTT INDIA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
STRIDES SHASUN LTD
Mar-16
ABBOTT INDIA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs6,0151,413 425.8%   
Low Rs3,707848 437.1%   
Sales per share (Unadj.) Rs1,236.9353.3 350.1%  
Earnings per share (Unadj.) Rs122.223.4 522.5%  
Cash flow per share (Unadj.) Rs129.041.0 314.7%  
Dividends per share (Unadj.) Rs35.005.00 700.0%  
Dividend yield (eoy) %0.70.4 162.8%  
Book value per share (Unadj.) Rs521.2320.4 162.7%  
Shares outstanding (eoy) m21.2589.35 23.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.93.2 122.8%   
Avg P/E ratio x39.848.3 82.3%  
P/CF ratio (eoy) x37.727.6 136.7%  
Price / Book Value ratio x9.33.5 264.4%  
Dividend payout %28.621.4 134.0%   
Avg Mkt Cap Rs m103,296100,988 102.3%   
No. of employees `0003.04.7 63.0%   
Total wages/salary Rs m3,3704,988 67.6%   
Avg. sales/employee Rs Th8,891.86,730.0 132.1%   
Avg. wages/employee Rs Th1,140.01,063.6 107.2%   
Avg. net profit/employee Rs Th878.3445.5 197.2%   
INCOME DATA
Net Sales Rs m26,28431,564 83.3%  
Other income Rs m5041,212 41.6%   
Total revenues Rs m26,78932,776 81.7%   
Gross profit Rs m3,6655,213 70.3%  
Depreciation Rs m1441,573 9.2%   
Interest Rs m81,803 0.4%   
Profit before tax Rs m4,0173,049 131.7%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m1,421689 206.4%   
Profit after tax Rs m2,5962,089 124.3%  
Gross profit margin %13.916.5 84.4%  
Effective tax rate %35.422.6 156.6%   
Net profit margin %9.96.6 149.2%  
BALANCE SHEET DATA
Current assets Rs m14,44635,949 40.2%   
Current liabilities Rs m4,72519,402 24.4%   
Net working cap to sales %37.052.4 70.5%  
Current ratio x3.11.9 165.0%  
Inventory Days Days5171 72.5%  
Debtors Days Days20127 15.4%  
Net fixed assets Rs m1,11334,478 3.2%   
Share capital Rs m213894 23.8%   
"Free" reserves Rs m10,80822,601 47.8%   
Net worth Rs m11,07628,632 38.7%   
Long term debt Rs m027,455 0.0%   
Total assets Rs m16,24176,591 21.2%  
Interest coverage x497.02.7 18,467.0%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.60.4 392.7%   
Return on assets %16.05.1 315.5%  
Return on equity %23.47.3 321.2%  
Return on capital %36.38.2 444.9%  
Exports to sales %0.648.1 1.3%   
Imports to sales %12.614.5 87.4%   
Exports (fob) Rs m16215,192 1.1%   
Imports (cif) Rs m3,3224,565 72.8%   
Fx inflow Rs m26816,612 1.6%   
Fx outflow Rs m3,9275,292 74.2%   
Net fx Rs m-3,65911,320 -32.3%   
CASH FLOW
From Operations Rs m2,514717 350.9%  
From Investments Rs m-800-22,284 3.6%  
From Financial Activity Rs m-80329,488 -2.7%  
Net Cashflow Rs m9128,073 11.3%  

Share Holding

Indian Promoters % 0.0 27.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 37.8 20.9%  
FIIs % 0.1 8.6 1.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 25.9 66.0%  
Shareholders   18,270 56,241 32.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  GSK PHARMA  PLETHICO PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 22, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS